- Home
- RNA vs AGNC Comparison
RNA vs AGNC Comparison
Compare RNA & AGNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNA | AGNC |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 12.6B |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNA | AGNC |
|---|---|---|
| Price | $14.93 | $10.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 12 |
| Target Price | ★ $69.26 | $11.03 |
| AVG Volume (30 Days) | 2.9M | ★ 17.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.21% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $88.12 | N/A |
| Revenue Next Year | $18.11 | $0.51 |
| P/E Ratio | ★ N/A | $7.69 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.06 | $7.85 |
| 52 Week High | $73.06 | $12.19 |
Technical Indicators
Market Signals| Indicator | RNA | AGNC |
|---|---|---|
| Relative Strength Index (RSI) | 4.22 | 29.29 |
| Support Level | $13.06 | $10.65 |
| Resistance Level | $72.52 | $11.58 |
| Average True Range (ATR) | 0.83 | 0.22 |
| MACD | -6.15 | -0.07 |
| Stochastic Oscillator | 3.11 | 3.76 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. The company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About AGNC AGNC Investment Corp.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.